… Thus, the aims of the present real-world study were to … in patients with AF and CKD, (2)
TTR in patients with AF and CKD treated with warfarin, (3) predictors of poor TTR in patients …

… This broad range of CRCL was selected to capture the vast majority of realworld patients.
Attributes of the simulated patients were identical for the labelled dosing and our proposed …

… Our measures of real-world behavior came from the Specific Level of Function Scale (SLOF) …
NP domains, functional capacity, and various domains of real-world performance were …

… concerns that patients with different levels of renal function in the real-world population may
… from all levels of eCrCl treated with warfarin were outside the therapeutic range roughly 37–…

… in patients’ conceptualization of their well-being. Nonetheless, the dominant factor which
constrains the range of human psychosocial functioning is the patient’s physical condition. As …

… real-world functional outcomes, recommended as the best available by a RAND expert panel,
were completed by patients … Possible scores on the advanced finances subtest range from …

… may begin with a simple decrease in physical activity, but can progress to include a wide
range of negative effects that often culminate in patients feeling out of control, lonely, and …

… , symptoms, and functional capacity. Neuropsychological … of real-world performance after
accounting for functional … real-world performance while not relating to functional capacity …

… these outcome represent a sensitive tool in real-life effectiveness studies. Our approach
reduced the … in the real-life, supporting the use of the drug in patients with different age range. …

… patient population with a wide range of comorbidities. The RE-LY (Randomized Evaluation
of Long-term anticoagulant therapY) and ARISTOTLE (Apixaban for Reduction In STroke and …